Dignostic Testing Solutions Manager @ (June 2021 - March 2024)
Clinical Market Development Manager @ (June 2019 - June 2021)
Senior Manager, Clinical Marketing @ (August 2017 - June 2019)
Senior Manager, Research and Development @ (December 2016 - August 2017)
Relationship Manager, Enterprise Business @ (October 2015 - December 2016)
Director, Research and Development @ (August 2011 - October 2015)
Xi Li Education
Nanyang Technological University Singapore
Ph.D. (Biomedical Engineering)
2006-2010
Tsinghua University
Bachelor (Biological Science)
1999-2003
Xi Li Skills
Assay Development
Biochemistry
Biotechnology
Business Development
CE-IVD
Cell Biology
Cell Culture
Clinical Market Development
Clinical Trials
DNA Sequencing
FDA
ISO 13485
IVD
Immunology
Infectious Diseases
LAMP
Laboratory Automation
Laboratory Management
Life Sciences
Lifesciences
Liquid Handling
Long Read Sequencing
Medical Devices
Microbiology
Microfluidics
Molecular Biology
Molecular Diagnostics
NGS
Next Generation Sequencing
Nucleic Acid Extraction
Oncology
PCR
Point of Care
Process Automation
Program Management
Project Management
R&D
RNA isolation
Real-Time Polymerase Chain Reaction (qPCR)
Resource Management
Sample Preparation
Sequencing
TGA
Team Management
Validation
Verification and Validation (V&V)
Virology
Western Blotting
qPCR
real-time PCR
Leadership
Public Speaking
Software
Ce Ivd
Customer Service
Reporting
Real Time Pcr
Real Time Polymerase Chain Reaction Qpcr
Real Time Polymerase Chain Reaction
Xi Li Summary
Xi Li, based in Singapore, is currently a Director, Diagnostic Testing Solutions at Oxford Nanopore Technologies. Xi Li brings experience from previous roles at Oxford Nanopore Technologies, PacBio and Thermo Fisher Scientific. Xi Li holds a 2006 - 2010 Ph.D. in Biomedical Engineering @ Nanyang Technological University Singapore. With a robust skill set that includes Assay Development, Biochemistry, Biotechnology, Business Development, CE-IVD and more. Xi Li has 2 emails on RocketReach.
Looking for a different Xi Li?
Find contact details for 700 million professionals.